Agneta Nordberg

Agneta Nordberg is a Professor of Clinical Neuroscience at Karolinska Institutet and Senior Consultant at Karolinska University Hospital. She leads the Translational Molecular Imaging Lab, focusing on neurodegenerative diseases like Alzheimer’s. Her work combines molecular imaging (PET/MRI) with clinical research to develop early diagnostic biomarkers and drug targets. Nordberg holds an MPharm, MD, and PhD from Uppsala University and has pioneered studies on cholinergic neurotransmission, amyloid PET imaging, and tau pathology visualization.

Her research emphasizes longitudinal studies in autosomal-dominant AD and Down’s syndrome, aiming to link imaging biomarkers (amyloid, tau, astrocytosis) with fluid biomarkers and cognitive outcomes. Key collaborations include universities in Sweden, Finland, the UK, and the USA. Nordberg has led over 15 clinical PET trials, received 15+ awards (e.g., 2020 European Grand Prix for Alzheimer Research), and published 500+ articles (H-index 79).

• Educations: MPharm, MD, PhD (Uppsala University)
• Grants: Swedish Research Council, SSF, EU IMI AMYPAD, and numerous foundations.

Her lab develops novel PET tracers for α-synuclein, 4R tau, and α7 nicotinic receptors. Research highlights include quantifying early pathological changes in neurodegenerative diseases and advancing multi-tracer imaging strategies for early diagnosis.

Awards:

• 2020 European Grand Prix for Alzheimer Research
• 2016 Grand Silver Medal from Karolinska Institutet
• 2014 Queen Silvia Prize

Her grants include the SSF-funded 'New Biomarkers in Early Diagnosis of AD' and the EU-funded INMIND and AMYPAD consortia. Nordberg’s work bridges bench-to-bedside, with a focus on translating imaging biomarkers into clinical practice.